Inflammatory marker profiles vary by BMI across Crohn’s disease, ulcerative colitis, psoriasis, and psoriatic arthritis - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Profiles of Inflammatory Markers Differ by Body Mass Index in Crohn’s Disease, Ulcerative Colitis, Psoriasis, and Psoriatic Arthritis

  • By

  • Stephen A. Shields

  • Ann Von Holle

  • Ruthvik Padival

  • Joseph F. Merola

  • Rachael Zuckerman

  • Jeff T. Mohl

  • Elizabeth L. Ciemins

  • July 17, 2026

Share

  • 1

    Obesity is linked to chronic low-grade inflammation, affecting systemic inflammatory markers in immune-mediated inflammatory diseases (IMIDs).

  • 2

    A longitudinal study analyzed 17,710 patients with Crohn’s disease, ulcerative colitis, psoriasis, or psoriatic arthritis over five years.

  • 3

    Patients with obesity showed significantly higher C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) compared to healthy-weight individuals.

  • 4

    Elevations in CRP and ESR persisted over five years, while ferritin levels showed near null associations across all conditions studied.

  • 5

    The findings suggest that excess adiposity contributes to systemic inflammatory burden in IMIDs, warranting further investigation.

Original Source(s)

Inflammatory marker profiles vary by BMI across Crohn’s disease, ulcerative colitis, psoriasis, and psoriatic arthritis

  • by Stephen A. Shields, Ann Von Holle, Ruthvik Padival, Joseph F. Merola, Rachael Zuckerman, Jeff T. Mohl, Elizabeth L. Ciemins

  • July 17, 2026

Related Content

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity

Spondyloarthritis function varies by sex

Women had greater functional deterioration over 17 years, while permanent work disability did not differ significantly between sexes.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.